Natural Killer T Cells in Cancer Immunotherapy

Shiny Nair,Madhav V. Dhodapkar
DOI: https://doi.org/10.3389/fimmu.2017.01178
IF: 7.3
2017-09-22
Frontiers in Immunology
Abstract:Natural killer T (NKT) cells are specialized CD1d-restricted T cells that recognize lipid antigens. Following stimulation, NKT cells lead to downstream activation of both innate and adaptive immune cells in the tumor microenvironment. This has impelled the development of NKT cell-targeted immunotherapies for treating cancer. In this review, we provide a brief overview of the stimulatory and regulatory functions of NKT cells in tumor immunity as well as highlight preclinical and clinical studies based on NKT cells. Finally, we discuss future perspectives to better harness the potential of NKT cells for cancer therapy.
immunology
What problem does this paper attempt to address?